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ABSTRACT Egg-laying hormone (ELH), a neuropeptide
synthesized by the bag cell neurons, induces egg laying and its
correlated behavior in Aplysia californica. In present study,
ELH has been purified to homogeneity and its primary structure
has been determined. We find this molecule to have 36 amino
acid residues with a M, of 4385 and a calculated isoelectric
point of 9.7. Direct microsequence analysis revealed a single
amino acid sequence that is in agreement with the amino acid
composition determined after acid hydrolysis of ELH: HRIle-
Ser-Ile-Asn-Gln-Asp-Leu-Lys-Ala-Ile-Thr-Asp-Met-Leu-Leu-
Thr-Glu-Gln-Ile-Arg-Glu-Arg-Gln-Arg-Tyr-Leu-Ala-Asp-Leu-
Arg-Gln-Arg-Leu-Leu-Glu-Lys-OH. Enzyme data indicate that
the COOR-terminal lysine may be modified but its exact nature
remains to be determined. There is no similarity between the
amino acid sequence of ELH and that of presently known ver-
tebrate neuropeptides. The two-step urification procedure,
starting with a homogenate of bag ce~l clusters, consisted of
cation exchange chromatography on SP C25 (Sephadex) followed
by gel filtration on Bio-Gel P4. Our purification results in a
10-fold enrichment of ELH from bag cell homogenates and a
36% recovery of purified radiolabeled marker ELH. Analysis
of purified ELH radiolabeled with [35S]methionine or [3HVleu-
cine on isoelectric focusing gels and on 8 M urea/sodium do-
decyl sulfate gels showed only a single peak containing 90% of
the radiolabel. Radiolabeled ELH migrated with a pI of 9.0-9.2and an apparent M, of 3500-5700. ELH retained egg-layingbioactivity when eluted from this segment of the gel. We find
that 2.5 nmol of pure ELH consistently induces egg laying at
200C.
In molluscs, a clear example of neurohormone-induced be-
havior is the egg laying in Aplysia californica evoked by a
neuropeptide egg-laying hormone (ELH) (1, 2). ELH is syn-
thesized by two symmetrical populations of about 400 neuro-
secretory bag cells each, clustered around the base of the
pleurovisceral connectives at the rostral edge of the abdominal
ganglion (3). When a homogenate of bag cells, containing ELH,
is injected into the hemocoel of a sexually mature animal, a
pattern of egg-laying behavior is triggered which results in egg
laying within 65 min at 14'C (1, 4). Egg-laying behavior typ-
ically consists of locomotion to a stationary position on a vertical
surface, puckering of mouth musculature, inhibition of feeding,
and increased frequency of head weaving movement, culmi-
nating in the extrusion and winding of the egg string into a
compact knot attached to the vertical substrate (5, 6).
Bag cell neurons are normally electrically silent but can be
triggered to produce a synchronous afterdischarge of action
potentials lasting 20-60 min when electrically stimulated (7).
Recent findings of gap junctions in bag cell clusters support the
premise that this synchrony of activity is due to electrical
coupling between bag cell neurons (8). In vitro experiments
have demonstrated the release of radiolabeled and bioactive
ELH only when bag cells afterdischarge (9). In vivo, such an
afterdischarge, whether induced or spontaneous, is always
followed by egg laying (10, 11).
Previous studies have characterized ELH as a basic peptide
of Mr approximately 6000 with an isoelectric point of 9.0-9.3
(12,13). We have purified ELH by a simple two-step procedure
to yield a homogeneous product with biological activity. We
find the molecule to be a polypeptide of 36 amino acids with
a calculated Mr of 4385 and migrating with a pI of 9.0-9.2. We
now report its amino acid sequence.
MATERIALS AND METHODS
Egg-Laying Bioassay. Material, at various stages of purifi-
cation, was checked for its ability to induce egg laying by in-
jection through the foot into the hemocoel of a sexually mature
A. californica maintained at 20'C as described (9). A test was
considered to be positive if eggs were sighted within 90 min of
injection. Injection volumes ranged from 1 to 3 ml and usually
consisted of an aliquot of test material in low-ionic strength
buffer mixed with an equal volume of filtered seawater.
Bag Cell Clusters, Radiolabeling, and Homogenization.
A. californica (>270 g) were dissected within 2 days after
collection from the Palos Verdes Peninsula during October and
November of 1977 and 1978. There is some correlation between
body weight and reproductive tract weight, and the latter, in
particular, is an indicator of sexual maturity (1). Our starting
material of bag cell clusters was obtained from sexually mature
animals. Bag cell clusters were cut free from the rest of the
abdominal ganglia in ice-cold filtered seawater and stored at
-200C.
For radiolabeling ELH, Millipore-filtered (0.22 ,gm) natural
seawater with a final concentration of 10 mM glucose was
buffered to pH 8.0 at 250C by 20 mM Na Hepes and supple-
mented with 150 1Ag each of K penicillin G and streptomycin
sulfate per ml. L-[4,53H]Leucine [250,uCi (1 Ci = 3.7 X 1010
becquerels); Amersham; specific activity, 100 Ci/mmoll or
[35Slmethionine (350 ,Ci; New England Nuclear; specific ac-
tivity, 450 Ci/mmol) was taken to dryness under forced air in
a boiling water bath and redissolved in the above medium.
Freshly dissected abdominal ganglia were incubated in radio-
labeled medium for 16 hr at room temperature (200C) and then
subjected to a series of rinses in filtered seawater lasting 2 hr.
The bag cell clusters were dissected out and kept frozen at
-20'C until used. To obtain radiolabeled ELH, 6 pairs of la-
beled clusters were ground with 34 pairs of unlabeled tissue.
In a typical preparation, 40 pairs of frozen bag cell clusters
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were homogenized by hand in ice-cold 10 mM Na phosphate
pH 6.0 (at 250C; standard buffer) with'phenylmethylsulfonyl
fluoride. The homogenate was centrifuged in a Sorvall RC 2B
at 12,000 X g for 20 min and the supernatant was dialyzed
(Spectrapor 3 membrane, cutoff at Mr 3500) against two
changes of 200 vol of standard buffer for 2 hr at 4VC. The re-
tained material was then ready for purification.
Total protein in samples was measured by absorbance at 215
nm with a Beckman DB-G spectrophotometer. The' sensitivity
was 0.052 A215 units/10 ,g of bovine serum albumin (used to
generate a standard curve) per ml.
Amino Acid Composition. For analysis of amino acid con-
tent, ELH was hydrolyzed in two ways: in 6 M HC1 under re-
duced pressure at 1100C for 24 hr, and in 3 M mercaptoe-
thanesulfonic acid under reduced pressure at 1100C for 24 hr.
Peptide fragments were subjected to the HCl hydrolysis only.
All amino analyses were performed on a Durrum D500 amino
acid analyzer.
Radiolabeled ELH was cleaved by 24-hr incubation in 6-fold
(wt/wt) excess cyanogen bromide in 70% formic acid under
nitrogen at 200C. The reaction was stopped by dilution with
distilled water, and the sample was frozen and lyophilized. In
one experiment, the reaction products, a mixture of whole
hormone and its cleavage products, were subjected directly to
sequence determination in tandem. In a second experiment,
the reaction products were redissolved in distilled water and
separated on Bio-Gel P-6 in 10 mM Na phosphate, pH 7.5/50
mM NaCl. The radioactive peak migrating with a much higher
Kay than ELH was again chromatographed on Bio-Gel P-2 and
then on Bio-Gel P-4, both equilibrated in 1 M acetic acid. After
these two additional steps of gel filtration, the major peak of
radiolabel was subjected to microsequence analysis and to 6 M
HCI hydrolysis and was found to be fragment 14-36 of
ELH.
Sequence Determination. Automated Edman degradation
was performed on the intact hormone and on the two peptides
generated by cyanogen bromide cleavage by using a sequenator
program similar to that described (14). The program included
a 30-min coupling step using 0.3 M Quadrol buffer, a single
5-min cleavage step, and automated conversion of the anili-
nothiazolinones to phenylthiohydantoin (>PhNCS) amino acids
by treatment with 25% aqueous trifluoroacetic acid for 45 min.
The cup and conversion flask were maintained at 520C.
The spinning cup sequenator used for the Edman degrada-
tion was designed and built at Caltech and will be described in
detail elsewhere. It incorporates many of the design features
described by Wittmann-Liebold (15) and Hunkapiller and
Hood (14), with further refinements in the delivery head as-
sembly and reagent/solvent reservoir system, and is equipped
with a straight-edge cup from Beckman.
Polybrene (Aldrich, 6 mg) and glycylglycine (100 nmol)
dissolved in 0.5 ml of distilled water were loaded into the se-
quenator cup and subjected to five complete degradation cycles.
The peptide to be sequenced was then loaded and the se-
quencing program commenced with the coupling stage.
>PhNCS amino acids were identified by high-performance
liquid chromatography (HPLC) on a DuPont Zorbax CN col-
umn. Details on identification of >PhNCS amino acids and
standard chromatograms are described elsewhere (16).
Isoelectric Focusing Gels (IEF). IEF gels were prepared and
run as reported (9). On extrusion, gels were immediately sliced
into 1.4-mm segments. To locate peaks of radioactivity, each
slice was added to 5 ml of Wilson's cocktail (17) for assay in a
Beckman LS scintillation counter.
Bioactivity was determined by incubation of gel segments
in two changes of standard buffer and injecting the combined
perfusates (total volume, 2 ml) into receptive test animals. To
obtain the pH gradient, an equivalent gel was run concurrently
and sliced into 2.8-mm segments, each of which was extracted
in 1 ml of 100mM KC1 for several hours; pH was then measured
directly with a Beckman Futura 39505 electrode and a Beck-
man Model 76 pH meter.
When 8 M urea 1EF gels were used, normal IEF gels were
made to 8 M urea and samples were brought to a final con-
centration of 3 M urea. Electrode buffers and other conditions
were identical to those of normal IEF gels. Gradients of pH
were similar in normal and urea IEF gels, and in both cases,
cytochrome c 'was used in every gel as a reference marker.
Sodium Dodecyl Sulfate (NaDodSO4) Gel Electrophoresis.
NaDodSO4/8 M urea slab gels were made according' to the
method of Swank and Munkres (18) with a final concentration
of 12.5% acrylamide and a bisacrylamide/acrylamide'ratio of
1:10. Standard mixtures of myoglobin (17,200), cytochrome c
(12,300),' a-bungarotoxin (7800), bovine pancreatic trypsin
inhibitor (6160), insulin (5700), and glucagon (3500) were ap-
plied to wells on either side of the sample and run simulta-
neously. Gels were run at 150C, to minimize diffusion, at a
constant voltage of 65 V for 12-18 hr. The length of the gel
containing the sample was then cut out and sliced, crosswise,
into 1.4-mm segments for assay of radioactivity as described
for IEF gels. The flanking slabs were stained and destained to
reveal standards.
RESULTS
Hormone Purification. All operations were carried out at
40C.
Cation exchange chromatography (SP C25 Sephadex). A
dialyzed homogenate of bag cell clusters was diluted with
standard buffer to a final volume of 30 ml and applied to a 6.0
X 1.5 cm column of SP C25, equilibrated to the standard buffer.
After a rinse with 50 ml of standard buffer, a linear gradient
made with 50 ml of standard buffer and 50 ml of 20 mM Na
phosphate, pH 6.5/250 mM NaCl was applied. Two major
peaks of protein 'were eluted at approximately 65 and 144 mM
NaCl (Fig. 1). Biological activity was observed only in the first
peak. Excluded material and rinse fractions also did not show
any biological activity. A flow rate of 30 ml/hr was generated
by gravity, and a Gilson microfractionator collected'80 fractions
(1.1 ml).
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FIG. 1. Sephadex SP C25 chromatography of supernatant of bag
cell extract after dialysis in standard buffer. Purified [3H]leucine-
labeled ELH was added as a marker to the supernatant. The column
(6.0 X 1.5 cm) was equilibrated with standard buffer, and a gradient
of 50 ml each of standard buffer and 20 mM Na phosphate, pH 6.5/250
mM NaCl was applied. The fraction volume was 1.1 ml and flow rate
was 30 ml/hr. A background of 20 cpm was subtracted. Bioactivity
coincided with the labeled marker ELH peak. Salt concentration was
measured by conductivity on a conductivity meter (type CDM 2d,
Radiometer, Copenhagen).
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Gel filtration (Bio-Gel P-6). After cation exchange chro-
matography, fractions of the biologically active peak (Fig. 1,
fractions 32-42) were pooled, lyophilized to a final volume of
0.8 ml, and applied onto a 50 X 1.0 cm Bio-Gel P-6 column
equilibrated with 10 mM Na phosphate, pH 7.5/100 mM NaCG.
Three protein peaks were seen in the A215 profile (Fig. 2). A
small peak of material was excluded followed by the major peak
of protein with a K5v of 0.2 (fractions 36-43) and another peak
eluting with a Kay of 0.9 (fractions 70-75). Biological activity
was only found in the major, middle peak, and this peak con-
tained only ELH.
When radiolabeled pure marker ELH was copurified with
an unlabeled bag cell cluster homogenate, the radioactive peak
of ELH comigrated only with biologically active fractions in
both steps of purification (Figs. 1 and 2).
In early experiments, a four-step procedure was used to pu-
rify ELH, which included ammonium sulfate precipitation and
anion exchange chromatography followed by the cation ex-
change chromatography and gel filtration steps described
above. ELH purified by this lengthy procedure was subjected
to partial sequence analysis and was found to be homogeneous
as judged by the presence of only one NH2-terminal sequence.
Later, the simpler two-step procedure was found to yield ELH
which, when sequenced, was identical in purity and content
to ELH obtained by the four-step method. Radiolabeled ma-
terial purified by either procedure produced only one radio-
active peak on IEF gels and on rechromatography on Bio-Gel
P-6.
Amino Acid Sequence and Composition of ELH. The
amino acid sequence of ELH and high-performance liquid
chromatography data from a sequenator run with 4 nmol of
intact hormone are shown in Fig. 3. Similar results were ob-
tained from runs with 2 nmol of the cyanogen bromide-cleaved
fragments. In Table 1, amino acid composition of ELH after
acid hydrolysis is compared with that obtained from sequence
data of the intact hormone. Because there is a decrease in yield
of subsequent amino acids as one progresses toward theCOOH
terminus during sequence determination, ELH14-6 was first
isolated and then examined to confirm the COOH-terminal half
of the molecule. Fragment 14-36 was obtained by cyanogen
bromide cleavage and was separated from undigested hormone
and from fragment 1-13 by gel filtration. This COOH-terminal
fragment was subjected to sequence determination and sepa-
rately hydrolyzed for amino acid composition (Table 1) For
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FIG. 2. Bio-Gel P-6 fractionation of biologically active material
after cation exchange chromatography (Fig. 1, fractions 32-42). This
material was pooled, concentrated to 0.6-0.8 ml, and applied to a 50
X 1 cm P-6 column equilibrated with 10 mM Na phosphate, pH
7;5/100 mM NaCl. Each fraction was 0.6 ml and flow rate was 4 ml/hr.
Radioactivity was from [3Hdleucine-labeled marker ELH.
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FIG. 3. Amino acid sequence of ELH and yields of >PhNCS
amino acids from an NH2-terminal sequenator analysis of 4 nmol of
the neuropeptide. Aliquots of each cycle were analyzed by high-per-
formance liquid chromatography; peak heights were converted to
nmol for each derivative by using values for standard mixtures of
>PhNCS amino acids and the yields were normalized to a 100% in-
jection.
both whole ELH and ELH1436, sequence content and amino
acid composition results match well. The COOH-terminal se-
quence was also confirmed by isolation of a tetrapeptide (Lys,
Glu, Leu2), from a tryptic digest of ELH succinylated in 5 M
guanidinium hydrochloride, that corresponds to the terminal
Leu-Leu-Glu-Lys sequence.
Isoelectric Focusing and Sodium Dodecyl Sulfate (Na-
DodSO4) Gel Analyses. When [3H]leucine-labeled purified
ELH was analyzed on normal IEF gels, 90% of total radioac-
tivity was recovered as a single peak in gel segments corre-
sponding to a pI of 9.0-9.2 (Fig. 4). Bioassayable activity was
eluted only from these regions of an equivalent gel. These re-
sults are identical to those of Arch and colleagues (13) in their
characterization of ELH. The profiles of [3H]ELH, biological
activity and marker cytochrome c were similar on both 8 M
urea and normal IEF gels.
For Mr analysis of polypeptides, radiolabeled ELH was run
on a 12.5% NaDodSO4/8 M Urea gel; 90% of total radioactivity
comigrated with insulin (Mr, 5700) and slightly ahead of a
marker of lower molecular weight, glucagon (Mr 3500) (Fig.
5).
ELH Recovery and Content. Table 2 summarizes the re-
Val
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Table 1. Comparison of amino acid contents of ELH and
ELH1436 determined from microsequence analysis
and from acid hydrolysis
ELH ELH1436*
a b c a b
Asx 4 3.8 4.0 1 1.3
Thr 2 1.7 1.9 1 0.7
Ser 1 0.7 0.7
Glx 7 7.2 7.4 6 6.4
Ala 2 2.1 2.4 1 1.1
Met 1 1.0 1.3
Ile 4 4.2 3.0 1 1.2
Leu 7 7.7 7.1 6 6.4
Tyr 1 0.9 1.1 1 0.5
Lys 2 1.9 2.2 1 1.1
Arg 5 4.5 4.8 5 5.0
Column a lists amino acid composition derived from microsequence
analysis. Column b lists molar ratios of amino acids obtained after 6
M HCl hydrolysis of the peptide. Column c lists molar ratios of amino
acids-obtained after hydrolysis by mercaptoethanesulfonic acid.
* ELH1436 was obtained from cyanogen bromide cleavage of intact
ELH followed by gel filtration.
covery of ELH during the two-step purification. When 117.5
Ag of purified [3H]leucine-labeled ELH was added to a di-
alyzed homogenate of 35 pairs of unlabeled bag cell clusters,
the specific activity of this mixture was 628 cpm/mg of total
protein. Upon elution with a salt gradient, 45% of counts applied
to the SP C25 column was recovered in the protein peak with
biological activity (Fig. 1) which had a specific activity of 46.8
cpm/,gg; 24% of the total radiolabel input was excluded by the
cation exchanger. Because the excluded material never ex-
hibited any biological activity, these excluded counts may
represent inactive fragments of ELH after proteolytic degra-
dation as a result of extraction. An alternate possibility is that
ELH has a high affinity for some other cell product and the
complex formed by their interaction neutralized the basic na-
ture of free ELH and prevented the retention of ELH by the
cation exchanger. If this were the case, the complexed ELH also
would have no biological activity.
After fractionation on Bio-Gel P-6, 80% of the applied ra-
dioactivity was recovered in fractions with a Ka. of 0.2 (Fig.
2). The specific activity of this purified ELH was 62.7 cpm/ug,
a 100-fold increase from the initial specific activity of 0.628
cpm//ug of the homogenate. A total recovery of 36% was de-
rived from the product of the percentage recoveries of radio-
label in the ELH peaks after cation exchange and gel filtra-
tion.
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Relative mobility
FIG. 4. Isoelectric focusing of purified [3H]leucine-labeled ELH
from fractions 36"43 of the Bio-Gel P-6 gel filtration (Fig. 2). The pH
gradient was obtained from an equivalent gel run concurrently. Mo-
bility is relative to the internal marker cytochrome c, pI 9.4-9.6.
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FIG. 5. NaDodSO48 M urea/12.5% polyacrylamide gel electro-
phoresis of purified [3H]leucine-labeled ELH from fractions 36-43
(Fig. 2). Slab gels were used and the six standards were applied to wells
flanking the sample well. Mobility of Coomassie blue-stained stan-
dards and of radioactivity in gel slices were calculated relative to that
of bromphenol blue.
DISCUSSION
We have established the purity and homogeneity of ELH
prepared by our procedures by four types of analysis: amino
acid sequence, amino acid composition, IEF, and Na-
DodSO4/polyacrylamide gel electrophoresis. Microsequence
analysis of purified ELH consistently revealed only one poly-
peptide chain. Moreover, it shows a good match with the amino
acid composition after conventional acid hydrolysis of biolog-
ically active ELH. There is therefore no evidence of the pres-
ence of a contaminantwith a blocked NH2 terminus that may
have copurified with the molecule analyzed. Gel analyses of
radiolabeled ELH revealed one band of radioactivity that mi-
grated with a pI of 9.0-9.2 on IEF gels and an apparent mass
of 5700-3500 daltons on 8 M urea/NaDodSO4 gels. In each
case, the single peak contained 90% of the total radioactivity
recovered on the gel. Biologically active material was eluted
only from these same regions of equivalent gels. A conclusive
demonstration of the identity of ELH will require that the
peptide be synthesized and shown to be bioactive.
Based on the amino acid sequence, ELH has a Mr of 4385.
Previous studies have characterized ELH as a 6000-dalton
peptide on the basis of gel filtration on Sephadex G-50 (12).
However, on Bio-Gel P-6 (exclusion size, Mr 6000) ELH is in
the included volume with a Ka. of 0.2 which is compatible with
a Mr of 4000-5000. On 8 M urea/NaDodSO4 gels, ELH co-
migrates with insulin (Mr 5700) and glucagon (Mr 3500).
However, the rate of migration on such gels may be greatly
affected by other considerations such as charge and shape,
particularly in the case of oligopeptides (18). Clearly, Na-
DodSO4 gels and gel filtration studies at best provide approxi-
mations of the Mr for such small peptides, and previous and
present data from such analyses are not incompatible with the
Mr of 4385 calculated from amino acid content. It is conceivable
that this mass could be increased if polysaccharides were asso-
ciated with ELH, although sequence analysis shows no poly-
saccharides.
The amino acid sequence revealed a greater number of basic
residues than acidic ones, which explains the basic nature of
ELH that persists even after denaturing by 8 M urea. If the
COOH-terminal residue is an unblocked lysine, calculated by
the method of Edsall and Wyman (19), the pI of ELH should
be 9.7, which agrees with the apparent pI of 9.0-9.2 on normal
and 8 M urea IEF gels. However, the inability of carboxypep-
tidases A and B to cleave ELH suggests a blocked COOH ter-
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Table 2. Recovery of purified, [3H]leucine-labeled ELH during copurification with unlabeled bag cell extract
Specific radioactivity, cpm/mg Total % recovery of initial
total protein radioactivity, cpm radioactivity
Bag cell extract supernatant* 628 50,000 100
After cation exchange chromatography,
fractions 32-42 (Fig. 1) 46,800 22,390 44.8
After gel filtration, fractions 35-45 (Fig. 2) 62,700 17,920 35.8
* Bag cell clusters (35 pairs) were homogenized and, after dialysis of the supernatant, 117.5,gg of [3H]leucine-labeled marker
ELH was added prior to purification.
minus, possibly by amidation. The majority of biologically
active neuropeptides, including substance P, LHRH, TRH,
oxytocin, and vasopressin, have amidated COOH termini. In
many cases, biological activity of the molecules requires the
presence of the terminal amide. Alternatively, cleavage of the
terminal lysine residue by carboxypeptidase B may be inhibited
by the presence of the penultimate glutamic acid residue or by
a peptide tertiary structure that shields the lysine from the
enzyme. At present, we do not have an answer to the nature of
the block at theCOOH terminus of ELH, which may affect the
calculated pI of the molecule.
Besides the basic character of ELH, the composition of this
molecule is also unusual in that it has no valine, proline, tryp-
tophan, histidine, glycine, phenylalanine, and cysteine. The
absence of cysteine means that disulfide linkages do not play
a role in intramolecular or intermolecular interactions with
ELH.
Our two-step procedure resulted in a 100-fold purification
of ELH based on specific activities in the recovery experiment
in Table 2. This suggests that ELH may make up as much as 1%
of the soluble protein in bag cell clusters. On the average, 7-14
,.g of hormone is recovered from a pair of bag cell clusters.
Because there is a 36% recovery of marker radiolabeled ELH,
the calculated initial level of the hormone is 19-39 A'g per
cluster pair. The actual value may be higher because we do not
know how efficient our method of extraction is, and ELH
contained in some of the bag cell terminals extending into the
abdominal ganglion and connective tissue have not been in-
cluded. Most of the clusters used were dissected from sexually
mature animals during October and November, at the height
of the reproductive season. This high ELH content may not be
maintained all year round.
The neuropeptide, ELH, whose primary structure has been
determined, is a molluskan neurohormone that is synthesized
by identifiable neuron clusters. A cardioexcitatory factor, the
tetrapeptide. amide Phe-Met-Arg-Phe-NH2, has been extracted
from the ganglia of clams, but the precise neuronal source and
its normal physiological role have still to be defined (20). The
atrial gland in the large hermaphroditic duct of Aplysia has
been shown to contain peptide factors capable of inducing egg
laying in Aplysia (21). Two of these peptide factors have re-
cently been purified in this laboratory and their sequence has
been determined (22). The two atrial peptides are rather similar
but they bear no resemblance to ELH, and their mode of action
in egg laying appears to be to produce bag cell afterdischarge
(22). ELH therefore remains as the only known neuropeptide
directly implicated in egg laying in Aplysia.
We thank Dr. L. K. Kaczmarek for comments on the manuscript
and Mr. Vince Farnsworth, Mr. Dan Viele, and Ms. Annette Yuen for
technical assistance. The work was funded by National Institutes of
Health Grants NS-07071 and NS-15183 to F.S., Grant GM-06965 to
L.E.H., and Biomedical Research Support Grant RR 07003 and by the
B.W. Foundation. Predoctoral support came from the Lawrence A.
Hanson Foundation Fellowship, Spencer Foundation Fellowship
(A.Y.C.), National Institutes of Health Training Grant GM-0086, and
the Arthur McCallum Fund (D.K.S.).
1. Strumwasser, F., Jacklet, J. W. & Alvarez, R. B. (1969) Comp.
Biochem. Physiol. 29,197-206.
2. Arch, S. (1976) Am. Zool. 16, 167-175.
3. Arch, S. (1972) J. Gen. Physiol. 60, 102-119.
4. Kupfermann, I. (1967) Nature (London) 216, 814-815.
5. Arch, S. & Smock, T. (1977) Behav. Biol. 19,45-54.
6. Stuart, D. K. & Strumwasser, F. (1979) J. Neurophysiol., in
press.
7. Kupfermann, I. & Kandel, E. R. (1970) J. Neurophysiol. 33,
865-876.
8. Kaczmarek, L. K., Finbow, M., Revel, J. P. & Strumwasser, F.
(1979) J. Neurobiol., in press.
9. Stuart, D. K:, Chiu, A. Y. & Strumwasser, F. (1979) J. Neuro-
physiol., in press.
10. Pinsker, H. M. & Dudek, F. E. (1977) Science 197,490-493.
11. Dudek, F. E., Cobbs, J. S. & Pinsker, H. M. (1979) J. Neuro-
physiol. 42, 804-817.
12. Toevs, L. A. S. (1970) Dissertation (California Institute of Tech-
nology, Pasadena, CA).
13. Arch, S., Early, P. & Smock, T. (1976) J. Gen. Physiol. 68,
197-210.
14. Hunkapiller, M. & Hood, L. E. (1978) Biochemistry 17,2124-
2133.
15. Wittmann-Liebold, B. (1973) Hoppe-Seyler's J. Physiol. Chem.
354, 1415-1431.
16. Nelson, N. J., Hunkapiller, M. & Hood, L. E. (1979) Anal. Bio-
chem., in press.
17. Ward, S., Wilson, D. L. & Gilliam, J. J. (1970) Anal. Biochem.
38,90-97.
18. Swank, R. T. & Munkres, K. D. (1971) Anal. Biochem. 39,
462-477.
19. Edsall, J. T. & Wyman, J. (1958) in Biophysical Chemistry (Ac-
ademic, New York), pp. 507-510.
20. Price, D. A. & Greenberg, M. J. (1977) Science 197,670-671.
21. Arch, S., Smock, T., Gurvis, R. & McCarthy, C. (1978) J. Comp.
Physiol. 128, 67-70.
22. Heller, E., Kaczmarek, L. K., Hunkapiller, M. & Strumwasser,
F. (1979) Soc. Neurosci. Abstr. 5,808.
6660 Neur'obiology: Chiu et al.
